Raymond James Initiates Coverage on Ardelyx (NASDAQ:ARDX)

Raymond James started coverage on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research note issued to investors on Monday, Marketbeat.com reports. The firm issued a strong-buy rating and a $12.00 price objective on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently issued reports on the stock. StockNews.com […]

Related Keywords

United States ,Raymond James ,Lauraa Williams ,Davidp Rosenbaum ,Ardelyx Inc ,Capital Partners ,Vanguard Group Inc ,Cantor Fitzgerald ,Deutsche Bank ,Free Report ,Trading Down ,Get Free Report ,Capital Management ,Adage Capital Partners ,Ardelyx Daily ,Ardelyx ,Nasdaq Ardx ,Cardx ,Medical ,Initiated Coverage ,